Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension

被引:3
|
作者
Hu, Song [1 ]
Tan, Jiang-Shan [1 ]
Liu, Sheng [2 ]
Guo, Ting-Ting [1 ]
Song, Wu [2 ]
Peng, Fu-Hua [1 ]
Wu, Yan [1 ]
Gao, Xin [1 ]
Hua, Lu [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Thrombosis Ctr,Natl Ctr Cardiovasc Dis,State Key, Natl Clin Res Ctr Cardiovasc Dis,Key Lab Pulm Vas, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Adult Cardiac Surg Ctr, Natl Ctr Cardiovasc Dis,Dept Cardiac Surg, Beijing, Peoples R China
关键词
ARTERIAL-HYPERTENSION; RISK STRATIFICATION; MANAGEMENT; HYPOXIA;
D O I
10.1016/j.amjcard.2021.09.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There remains a lack of prognosis models for patients with chronic thromboembolic pulmonary hypertension (CTEPH). This study aims to develop a nomogram predicting 3-, 5-, and 7-year survival in patients with CTEPH and verify the prognostic model. Patients with CTEPH diagnosed in Fuwai Hospital were enrolled consecutively between May 2013 and May 2019. Among them, 70% were randomly split into a training set and the other 30% as a validation set for external validation. Cox proportional hazards model was used to identify the potential survival-related factors which were candidate variables for the establishment of nomogram and the final model was internally validated by the bootstrap method. A total of 350 patients were included in the final analysis and the median followup period of the whole cohort was 51.2 months. Multivariate analysis of Cox proportional hazards regression showed body mass index, mean right atrial pressure, N-terminal probrain natriuretic peptide (per 500 ng/ml increase in concentration), presence of anemia, and main treatment choice were the independent risk factors of mortality. The nomogram demonstrated good discrimination with the corrected C-index of 0.82 in the training set, and the C-index of 0.80 (95% CI: 0.70 to 0.91) in the external validation set. The calibration plots also showed a good agreement between predicted and actual survival in both training and validation sets. In conclusion, we developed an easy-to-use nomogram with good apparent performance using 5 readily available variables, which may help physicians to identify CTEPH patients at high risk for poor prognosis and implement medical interventions. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [31] Development and Validation of a Nomogram for Predicting Postoperative Pulmonary Infection in Patients Undergoing Lung Surgery
    Wang, Jing-Yun
    Pang, Qian-Yun
    Yang, Ya-Jun
    Feng, Yu-Mei
    Xiang, Ying-Ying
    An, Ran
    Liu, Hong-Liang
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (12) : 4393 - 4402
  • [32] Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial
    Simonneau, Gerald
    D'Armini, Andrea M.
    Ghofrani, Hossein-Ardeschir
    Grimminger, Friedrich
    Jansa, Pavel
    Kim, Nick H.
    Mayer, Eckhard
    Pulido, Tomas
    Wang, Chen
    Colorado, Pablo
    Fritsch, Arno
    Meier, Christian
    Nikkho, Sylvia
    Hoeper, Marius M.
    LANCET RESPIRATORY MEDICINE, 2016, 4 (05) : 372 - 380
  • [33] Multiple Beneficial Effects of Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension
    Tatebe, Shunsuke
    Sugimura, Koichiro
    Aoki, Tatsuo
    Miura, Masanobu
    Nochioka, Kotaro
    Yaoita, Nobuhiro
    Suzuki, Hideaki
    Sato, Haruka
    Yamamoto, Saori
    Satoh, Kimio
    Fukumoto, Yoshihiro
    Shimokawa, Hiroaki
    CIRCULATION JOURNAL, 2016, 80 (04) : 980 - +
  • [34] Support Experienced by Patients Living with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Ivarsson, Bodil
    Ekmehag, Bjorn
    Sjoberg, Trygve
    HEART LUNG AND CIRCULATION, 2016, 25 (01) : 35 - 40
  • [35] Right Ventricular Dyssynchrony in Patients With Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
    Yamagata, Yuki
    Ikeda, Satoshi
    Kojima, Sanae
    Ueno, Yuki
    Nakata, Tomoo
    Koga, Seiji
    Ohno, Chikara
    Yonekura, Tsuyoshi
    Yoshimuta, Tsuyoshi
    Minami, Takako
    Kawano, Hiroaki
    Maemura, Koji
    CIRCULATION JOURNAL, 2022, 86 (06) : 936 - +
  • [36] Development and validation of a Prediction Model for Chronic Thromboembolic Pulmonary Disease
    Liu, Guixiang
    Wen, Jing
    Lv, Chunyi
    Liu, Mingjie
    Li, Min
    Fang, Kexia
    Fei, Jianwen
    Zhang, Nannan
    Li, Xuehua
    Wang, Huarui
    Sun, Yuanyuan
    Zhu, Ling
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [37] The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension
    Wronski, Samantha L.
    Mordin, Margaret
    Kelley, Kim
    Anguiano, Rebekah H.
    Classi, Peter
    Shen, Eric
    Manaker, Scott
    LUNG, 2020, 198 (01) : 65 - 86
  • [38] Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors
    Dong, Shenghua
    Liang, Jun
    Zhai, Wenxin
    Yu, Zhuang
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (09): : 607 - 614
  • [39] Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma
    Zhang, Yaodong
    Wu, Zhengshan
    Wang, Xing
    Li, Changxian
    Chang, Jiang
    Jiang, Wangjie
    Wang, Hongwei
    Wang, Yirui
    Li, Xiangcheng
    BMC CANCER, 2020, 20 (01)
  • [40] Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease
    Sarc, Irena
    Jeric, Tina
    Ziherl, Kristina
    Suskovic, Stanislav
    Kosnik, Mitja
    Anker, Stefan D.
    Lainscak, Mitja
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2011, 17 (04) : 737 - 743